Nelly, do you have any thoughts on that, or more broadly, what's working and what's, you know, where is the biggest gap right now?

Yeah, I think I agree with Norbert.

What's-- has, you know, proven to work is this triaging step where we can, uh, we can implement AI both for, uh, you know, predicting attributes that we're looking for the molecules as well as better-- having better diversity based on structure prediction.

So I...

To your question of, you know, has it-- do we have proof of this working? I'll mention that we did actually this study.

It's, it's a few years, it's, it's before my time, that this AI-enabled sort of intelligent triaging mech-- workflow has been established in the discovery organization in Lilly, and they did a study to look at molecules that get to development and their sort of success rate.

And significantly, the, the number of, uh, you know, uh, surprises or, or liabilities that development gets has been reduced, uh, during this time.

Melody, do you have thoughts on data different than that's been shared already or different areas we should think about?